Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders and Presentation
May 20 2005 - 8:15AM
PR Newswire (US)
Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders
and Presentation SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast their Annual
Meeting of Stockholders on Wednesday, May 25, 2005 at 10:00 a.m.
Pacific Time from the company's corporate headquarters in San
Diego, CA. Following the Annual Meeting, Ginger Graham, President
and Chief Executive Officer of Amylin Pharmaceuticals, will be
providing a corporate overview, and Dr. Steven Edelman, Professor
of Medicine, Division of Endocrinology & Metabolism, University
of San Diego and Director, Diabetes Care Clinic, Veterans Affairs
Medical Center, San Diego, will provide a physician's perspective
on current diabetes treatments. The live presentation will be
webcast, and a recording will be made available following the
event. The webcast and recording will be accessible through
Amylin's corporate website, located at http://www.amylin.com/. To
access the live webcast, please log on to Amylin's site
approximately fifteen minutes prior to the presentation to register
and download any necessary audio software. Amylin Pharmaceuticals
is a biopharmaceutical company committed to improving lives through
the discovery, development and commercialization of innovative
medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark
G. Foletta, Vice President Finance and Chief Financial Officer of
Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024